Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Mechanisms of liver disease in patients infected with HIV.

Kaspar MB, Sterling RK.

BMJ Open Gastroenterol. 2017 Oct 26;4(1):e000166. doi: 10.1136/bmjgast-2017-000166. eCollection 2017. Review.

2.

The proportion of different interleukin-17-producing T-cell subsets is associated with liver fibrosis in chronic hepatitis C.

Cachem FCOF, Dias AS, Monteiro C, Castro JR, Fernandes G, Delphim L, Almeida AJ, Tavares F, Maciel AMA, Amendola-Pires MM, Brandão-Mello CE, Bento CAM.

Immunology. 2017 Jun;151(2):167-176. doi: 10.1111/imm.12720. Epub 2017 Mar 13.

PMID:
28140446
3.

Mechanisms of Accelerated Liver Fibrosis Progression during HIV Infection.

Debes JD, Bohjanen PR, Boonstra A.

J Clin Transl Hepatol. 2016 Dec 28;4(4):328-335. doi: 10.14218/JCTH.2016.00034. Epub 2016 Nov 21. Review.

4.

Frontline Science: HIV infection of Kupffer cells results in an amplified proinflammatory response to LPS.

Mosoian A, Zhang L, Hong F, Cunyat F, Rahman A, Bhalla R, Panchal A, Saiman Y, Fiel MI, Florman S, Roayaie S, Schwartz M, Branch A, Stevenson M, Bansal MB.

J Leukoc Biol. 2017 May;101(5):1083-1090. doi: 10.1189/jlb.3HI0516-242R. Epub 2016 Dec 16.

PMID:
27986871
5.

Microbial Translocation Associated with an Acute-Phase Response and Elevations in MMP-1, HO-1, and Proinflammatory Cytokines in Strongyloides stercoralis Infection.

Rajamanickam A, Munisankar S, Bhootra Y, Dolla C, Nutman TB, Babu S.

Infect Immun. 2016 Dec 29;85(1). pii: e00772-16. doi: 10.1128/IAI.00772-16. Print 2017 Jan.

6.

Gut epithelial barrier dysfunction in human immunodeficiency virus-hepatitis C virus coinfected patients: Influence on innate and acquired immunity.

Márquez M, Fernández Gutiérrez del Álamo C, Girón-González JA.

World J Gastroenterol. 2016 Jan 28;22(4):1433-48. doi: 10.3748/wjg.v22.i4.1433. Review.

7.

Association between IL7R polymorphisms and severe liver disease in HIV/HCV coinfected patients: a cross-sectional study.

Guzmán-Fulgencio M, Berenguer J, Jiménez-Sousa MA, Pineda-Tenor D, Aldámiz-Echevarria T, García-Broncano P, Carrero A, García-Álvarez M, Tejerina F, Diez C, Vazquez-Morón S, Resino S.

J Transl Med. 2015 Jun 30;13:206. doi: 10.1186/s12967-015-0577-y.

8.

The dormant blood microbiome in chronic, inflammatory diseases.

Potgieter M, Bester J, Kell DB, Pretorius E.

FEMS Microbiol Rev. 2015 Jul;39(4):567-91. doi: 10.1093/femsre/fuv013. Epub 2015 May 3. Review.

9.

Low levels of microbial translocation marker LBP are associated with sustained viral response after anti-HCV treatment in HIV-1/HCV co-infected patients.

Nyström J, Stenkvist J, Häggblom A, Weiland O, Nowak P.

PLoS One. 2015 Mar 18;10(3):e0118643. doi: 10.1371/journal.pone.0118643. eCollection 2015.

10.

Molecular mechanisms of liver fibrosis in HIV/HCV coinfection.

Mastroianni CM, Lichtner M, Mascia C, Zuccalà P, Vullo V.

Int J Mol Sci. 2014 May 26;15(6):9184-208. doi: 10.3390/ijms15069184. Review.

11.

Hepatitis B and C co-infection among HIV-infected adults while on antiretroviral treatment: long-term survival, CD4 cell count recovery and antiretroviral toxicity in Cambodia.

van Griensven J, Phirum L, Choun K, Thai S, De Weggheleire A, Lynen L.

PLoS One. 2014 Feb 12;9(2):e88552. doi: 10.1371/journal.pone.0088552. eCollection 2014.

12.

Immune activation in HIV/HCV-infected patients is associated with low-level expression of liver expressed antimicrobial peptide-2 (LEAP-2).

Shata MT, Abdel-Hameed EA, Hetta HF, Sherman KE.

J Clin Pathol. 2013 Nov;66(11):967-75. doi: 10.1136/jclinpath-2013-201581. Epub 2013 Aug 12.

13.

Microbial translocation and liver disease progression in women coinfected with HIV and hepatitis C virus.

French AL, Evans CT, Agniel DM, Cohen MH, Peters M, Landay AL, Desai SN.

J Infect Dis. 2013 Aug 15;208(4):679-89. doi: 10.1093/infdis/jit225. Epub 2013 May 17.

14.

Immune biomarker differences and changes comparing HCV mono-infected, HIV/HCV co-infected, and HCV spontaneously cleared patients.

Kushner LE, Wendelboe AM, Lazzeroni LC, Chary A, Winters MA, Osinusi A, Kottilil S, Polis MA, Holodniy M.

PLoS One. 2013 Apr 4;8(4):e60387. doi: 10.1371/journal.pone.0060387. Print 2013.

15.

Complementary role of HCV and HIV in T-cell activation and exhaustion in HIV/HCV coinfection.

Feuth T, Arends JE, Fransen JH, Nanlohy NM, van Erpecum KJ, Siersema PD, Hoepelman AI, van Baarle D.

PLoS One. 2013;8(3):e59302. doi: 10.1371/journal.pone.0059302. Epub 2013 Mar 15.

16.

Opportunities in proteomics to understand hepatitis C and HIV coinfection.

Meissner EG, Suffredini AF, Kottilil S.

Future Virol. 2012 Aug;7(8):759-765.

17.

Microbial translocation and infectious diseases: what is the link?

D'Ettorre G, Douek D, Paiardini M, Ceccarelli G, Vullo V.

Int J Microbiol. 2012;2012:356981. doi: 10.1155/2012/356981. Epub 2012 Oct 4. No abstract available.

18.

Microbial translocation, immune activation, and HIV disease.

Klatt NR, Funderburg NT, Brenchley JM.

Trends Microbiol. 2013 Jan;21(1):6-13. doi: 10.1016/j.tim.2012.09.001. Epub 2012 Oct 11. Review.

19.

Evidence of microbial translocation associated with perturbations in T cell and antigen-presenting cell homeostasis in hookworm infections.

George PJ, Anuradha R, Kumar NP, Kumaraswami V, Nutman TB, Babu S.

PLoS Negl Trop Dis. 2012;6(10):e1830. doi: 10.1371/journal.pntd.0001830. Epub 2012 Oct 4.

Supplemental Content

Support Center